Clinical Trials
Study Title:
A Phase 1/2 Open label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Advanced Solid Tumors Harboring a p53 Y220C Mutation (PYNNACLE)
|
For more information about the trial above please contact the study team:
Medical University of South Carolina
Principal Investigator, John Kaczmar, at kaczmar@musc.edu, or please call +1 843-792-6691.
Study Coordinator, Holly Boggan, at bogganhl@musc.edu, or please call +1 843-813-5663.
Trial opened at the following institutions: Medical University of South Carolina |